Medicare Enrolled

Dr. Nabil Yazgi, MD, PA

Optician · Wayne, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
401 HAMBURG TPKE STE 102, Wayne, NJ 07470
9737901180
In practice since 2006 (19 years)
NPI: 1144337908 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yazgi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yazgi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yazgi

Dr. Nabil Yazgi is an optician specialist in Wayne, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yazgi performed 322 Medicare services across 157 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yazgi received a total of $8,916 from 69 pharmaceutical and/or device companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yazgi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 322 Medicare services $8,916 industry payments

Medicare Practice Summary

Medicare Utilization ↗
322
Medicare services
Bottom 25% in NJ for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
157
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
167 $95 $130
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
64 $122 $170
New patient office visit, complex (60-74 min) 40 $180 $300
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
34 $89 $250
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
17 $221 $1,850
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,916
Total received (2018-2024)
Avg $1,274/year across 7 years
Top 11% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
670
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,607 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$309 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,612
2023
$1,317
2022
$1,626
2021
$1,538
2020
$1,102
2019
$954
2018
$768

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$235
SCILEX PHARMACEUTICALS INC.
$205
ABBVIE INC.
$198
Novartis Pharmaceuticals Corporation
$138
Collegium Pharmaceutical, Inc.
$90
Celgene Corporation
$84
PFIZER INC.
$83
UCB, Inc.
$77
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$61
Neurocrine Biosciences, Inc.
$58
ARGENX US, INC.
$57
GE HEALTHCARE
$52
Lundbeck LLC
$36
PROTEGA PHARMACEUTIALS INC
$31
Eisai Inc.
$31
Kyowa Kirin, Inc.
$29
Biogen, Inc.
$18
Virtus Pharmaceuticals LLC
$18
ANI Pharmaceuticals, Inc.
$18
Amneal Pharmaceuticals LLC
$16
AstraZeneca Pharmaceuticals LP
$16
Lilly USA, LLC
$16
Axsome Therapeutics, Inc.
$15
CSL Behring
$14
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$692
Novartis Pharmaceuticals Corporation
$532
ABBVIE INC.
$502
Allergan, Inc.
$408
UCB, Inc.
$399
SCILEX PHARMACEUTICALS INC.
$380
Lilly USA, LLC
$359
Collegium Pharmaceutical, Inc.
$342
AbbVie Inc.
$325
Celgene Corporation
$316
Teva Pharmaceuticals USA, Inc.
$306
NOVARTIS PHARMACEUTICALS CORPORATION
$258
Supernus Pharmaceuticals, Inc.
$256
Biogen, Inc.
$250
PFIZER INC.
$199
Eisai Inc.
$198
Scilex Pharmaceuticals Inc.
$172
Biohaven Pharmaceutical Holding Company Ltd.
$152
Allergan Inc.
$150
Amgen Inc.
$146
Amneal Pharmaceuticals LLC
$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$125
Adamas Pharmaceuticals, Inc.
$116
Kyowa Kirin, Inc.
$114
Biohaven Pharmaceuticals, Inc.
$113
Merck Sharp & Dohme Corporation
$110
Janssen Pharmaceuticals, Inc
$94
Lundbeck LLC
$92
Stryker Corporation
$87
Neurocrine Biosciences, Inc.
$85
SK Life Science, Inc.
$78
Merck Sharp & Dohme LLC
$77
CSL Behring
$77
GE HealthCare
$76
E.R. Squibb & Sons, L.L.C.
$73
Abbott Laboratories
$71
GE HEALTHCARE
$65
Neurelis, Inc.
$62
ARGENX US, INC.
$57
Upsher-Smith Laboratories LLC
$56
Acorda Therapeutics, Inc
$54
EISAI INC.
$53
Mallinckrodt Hospital Products Inc.
$48
LivaNova USA, Inc.
$47
UPSHER-SMITH LABORATORIES LLC
$46
AstraZeneca Pharmaceuticals LP
$44
Virtus Pharmaceuticals LLC
$43
Alexion Pharmaceuticals, Inc.
$43
US WorldMeds, LLC
$41
Medtronic USA, Inc.
$35
PROTEGA PHARMACEUTIALS INC
$31
Impax Laboratories, Inc.
$30
ACADIA Pharmaceuticals Inc
$26
Sentynl Therapeutics, Inc.
$25
Purdue Pharma L.P.
$24
IMPEL PHARMACEUTICALS INC.
$23
ANI Pharmaceuticals, Inc.
$18
Mallinckrodt Enterprises LLC
$16
Almatica Pharma LLC
$16
GRT US Holding, Inc.
$15
Merz Pharmaceuticals, LLC
$15
Vertical Pharmaceuticals, LLC
$15
Axsome Therapeutics, Inc.
$15
Avion Pharmaceuticals
$15
GENZYME CORPORATION
$14
Sumitomo Pharma America, Inc.
$14
MDD US Operations, LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$13
Egalet US Inc
$12
Top 3 companies account for 19.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · Belbuca · Briviact · COMIRNATY · Cambia · DIVIGEL · Dhivy · ELYXYB - CELECOXIB · EMGALITY · Fycompa · GILENYA · GOCOVRI · GRALISE · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · LEVORPHANOL TARTRATE · LYRICA · Leqembi · Levorphanol Tartrate · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · ONGENTYS · OXAYDO · OXTELLAR XR · OXYCONTIN · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · Qutenza · RELISTOR · ROXYBOND · RYTARY · SOLIRIS · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART HYTRULO · XTAMPZA · XTAMPZAER · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Wayne?
Compare opticians in the Wayne area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
6,656
Per 100K population
1284.2
County median income
$87,137
Nearest hospital
CHILTON MEDICAL CENTER
3.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yazgi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yazgi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yazgi performed 167 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yazgi receive payments from pharmaceutical companies?
Yes. Dr. Yazgi received a total of $8,916 from 69 companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yazgi's costs compare to other opticians in Wayne?
Dr. Yazgi's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yazgi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →